G C Antonini Cappellini

Learn More
BACKGROUND Ipilimumab improves the survival of metastatic melanoma patients. Despite documented, durable objective responses, a significant number of patients fails to benefit from treatment. The aim of this study was to identify an upfront marker for treatment benefit. METHODS A total of 187 metastatic melanoma patients treated in three Italian(More)
  • 1